Myricetin, a natural inhibitor of CD147, increases sensitivity of cisplatin in ovarian cancer-Reference-Cited by-同舟云学术

Myricetin, a natural inhibitor of CD147, increases sensitivity of cisplatin in ovarian cancer

Published:2024-01-23 Issue:1-2 Volume:28 Page:83-95
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Chen Lin¹,Fan Tian²,Wang Miao²,Zhu Chun-Yu²,Feng Wang-You¹,Li Yu²,Yang Hong¹

Affiliation:

1. Department of Obstetrics and Gynecology, Xijing Hospital, Fourth Military Medical University, Xi’an, China

2. Laboratory of Cell Biology, Institute of Medical Research, Northwestern Polytechnical University, Xi’an, China

Funder

Collaborative Research Project of Universities

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2024.2306345

Reference55 articles.

1. Cancer statistics, 2022

2. Epithelial ovarian cancer

3. Distribution of ACE2, CD147, CD26, and other SARS‐CoV‐2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID‐19 risk factors

4. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily;Biswas C;Cancer Res,1995

5. MALIGNANT HYPERTHERMIA IN A PARTURIENT POLAND CHINA SOW

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening potential antileukemia agents from duckweed: Integration of chemical profiling, network pharmacology, and experimental validation;Phytochemical Analysis;2024-06-25

2. Comparative assessment of different anti-CD147/Basigin 2 antibodies as a potential therapeutic anticancer target by molecular modeling and dynamic simulation;Molecular Diversity;2024-04-08